BIOHAVEN PHARMACEUTICAL
Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.
BIOHAVEN PHARMACEUTICAL
Industry:
Biotechnology Health Care Health Diagnostics Neuroscience Pharmaceutical
Founded:
2013-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.biohavenpharma.com
Total Employee:
1001+
Status:
Active
Total Funding:
443.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Mobile Non Scaleable Content IPv6 Google Maps ReCAPTCHA Cloudflare JS CDN JS
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-01-07 | Kleo | Kleo acquired by Biohaven Pharmaceutical | 20 M USD |
Investors List
Soros Fund Management
Soros Fund Management investment in Post-IPO Equity - Biohaven Pharmaceutical
Venrock
Venrock investment in Venture Round - Biohaven Pharmaceutical
RA Capital Management
RA Capital Management investment in Venture Round - Biohaven Pharmaceutical
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Biohaven Pharmaceutical
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Venture Round - Biohaven Pharmaceutical
Aisling Capital
Aisling Capital investment in Venture Round - Biohaven Pharmaceutical
Greg Bailey
Greg Bailey investment in Venture Round - Biohaven Pharmaceutical
Knoll Capital Management
Knoll Capital Management investment in Venture Round - Biohaven Pharmaceutical
Connecticut Innovations
Connecticut Innovations investment in Venture Round - Biohaven Pharmaceutical
Litmore Capital
Litmore Capital investment in Venture Round - Biohaven Pharmaceutical
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-03-01 | Artizan Biosciences | Biohaven Pharmaceutical investment in Series A - Artizan Biosciences | 18.88 M USD |
2018-11-14 | Kleo | Biohaven Pharmaceutical investment in Series B - Kleo | 21 M USD |
2016-09-01 | Kleo | Biohaven Pharmaceutical investment in Series A - Kleo | N/A |
Official Site Inspections
http://www.biohavenpharma.com Semrush global rank: 1.11 M Semrush visits lastest month: 29.03 K
- Host name: ec2-3-130-137-99.us-east-2.compute.amazonaws.com
- IP address: 3.130.137.99
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215

More informations about "Biohaven Pharmaceutical"
Commitment to Patients, Winning with Science
Biohaven is dedicated to following science, continuously striving to evolve our approach to drug discovery and development to help people live healthier lives. To enhance our ability to deliver enduring value, we have combined internal …See details»
Biohaven Pharmaceutical
3 days ago Biohaven was founded in 2013 by a team of experienced biopharma professionals dedicated to rapid development and commercialization of innovative treatments for patients …See details»
Overview - Biohaven, Ltd.
Jan 13, 2025 Biohaven, Ltd. focuses on developing and commercializing innovative treatments for neurological, immunological, and oncological conditions.See details»
Biohaven Pharmaceuticals – Valuation, Revenue & Market Scope
Organization biohavenpharma.com Location New Haven , Connecticut , United States Industry BiotechSee details»
Biohaven Pharmaceutical Org Chart + Executive Team
The org chart of Biohaven Pharmaceutical contains its 120 main executives like Vlad Coric, Matthew Buten and John Tilton.See details»
Biohaven Pharmaceutical - Craft
See insights on Biohaven Pharmaceutical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Biohaven Pharmaceutical - VentureRadar
Biohaven is a clinical-stage biopharmaceutical company dedicated to advancing novel, life-changing therapies for neurological and neuropsychiatric diseases, including rare disorders. …See details»
Biohaven Pharmaceutical - Crunchbase Company …
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.See details»
Biohaven Pharmaceutical Holding Company Ltd.
Biohaven is a biopharmaceutical company focused on the development and commercialization of innovative best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases. …See details»
Biohaven Pharmaceutical Holding Company, Ltd Information
Biohaven Pharmaceutical Holding Company, Ltd is a Drug Manufacturing & Research, Biotechnology, and Neuroscience company located in New Haven, Connecticut with $155.6 …See details»
Biohaven - LinkedIn
Biohaven | 53,274 followers on LinkedIn. A modern pharmaceutical company guided by science and inspired to change the lives of people with unmet medical needs. | Biohaven is a uniquely …See details»
Biohaven Pharmaceuticals - Employees, Contact info, Overview
Apr 30, 2024 View info about Biohaven Pharmaceuticals (biohavenpharma.com). Biohaven Pharmaceuticals is a company located in New Haven, CT, United States. Find employees, …See details»
Biohaven Pharmaceutical - 2025 Company Profile & Team - Tracxn
Jul 15, 2025 Biohaven Pharmaceutical - Developer of therapies targeting neurological and neuropsychiatric diseases. Acquired by Pfizer. Raised a total funding of $84.1M over 3 rounds …See details»
Biohaven - Overview, News & Similar companies | ZoomInfo.com
View Biohaven (www.biohaven.com) location in Connecticut, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Biohaven Pharmaceuticals | Life Sciences PA
Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies for people with debilitating …See details»
Biohaven Company Profile | Management and Employees List
Find contact information for Biohaven. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Biohaven's email format.See details»
Biohaven Pharmaceutical Holding Company Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biohaven Pharmaceutical Holding Company Ltd. of New Haven, CT. Get the latest business insights …See details»
Biohaven Pharmaceutical Holding Co. Ltd.:Company Profile
Discovery Company profile page for Biohaven Pharmaceutical Holding Co. Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Jun 30, 2017 Biohaven Pharmaceutical Holding Company Ltd. is a United States-based commercial-stage biopharmaceutical company. The Company has a portfolio of therapies to …See details»
Biohaven Pharmaceuticals Company Overview, Contact Details ...
Learn more about Biohaven Pharmaceuticals's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»